PHYSICIANS: New Codes Split Components Of Flow Cytometry

Why This Topic Matters

It helps readers evaluate whether the article is relevant to coding and reimbursement changes for laboratory services, especially in hematology and oncology-related testing. The topic is important because payment methodology changes can affect reporting, interpretation, and patient access to specialized diagnostic services.

Article Sections

1. Medicare physician fee schedule changes

   Overview of the reimbursement context and the policy changes affecting flow cytometry services under the physician fee schedule.

2. Provider concerns about access and payment

   Discussion of physician and laboratory stakeholder comments about the impact of the changes on payment, access, and service availability.

3. CMS response and rationale

   Summary of CMS’ explanation for revising how the service is recognized and priced, along with the agency’s request for additional pricing information.

4. Clinical use in leukemia evaluation

   Broad discussion of how the service is used in hematology practice and why different testing approaches may require different levels of expertise.

5. Comment period and possible next steps

   Brief coverage of CMS’ invitation for public comments and the potential for future rulemaking or interim fee schedule changes.